We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
We use cookies to distinguish you from other users and to provide you with a better experience on our websites. Close this message to accept cookies or find out how to manage your cookie settings.
from SECTION 2 - THE TRANSLATION OF BIOLOGY TO THE CLINIC
Published online by Cambridge University Press: 05 February 2014
Introduction
Major advances have taken place in our understanding of the biology of cancer but it has often seemed that this has not been translated into breakthroughs in new treatments, particularly in ovarian cancer where first-line management for the disease has not changed in 20 years.
The benefits of an increasing knowledge of the biology of the disease should, however, be two-fold — identifying new targets against which drugs can be developed and being able to identify which tumours are most likely to respond to these drugs. To be able to move away from the ‘one size fits all’ mentality of current cytotoxic therapy towards an individualised, targeted therapy remains the holy grail of current cancer medicine.
The story of the development of polyadenosine diphosphate-ribose polymerase (PARP) inhibitors and their link with the homologous recombination (HR) DNA repair pathway is the first real example in ovarian cancer of this process being carried through from the laboratory to the clinic. This chapter outlines the DNA repair pathways involved in PARP inhibitor sensitivity, how deficiencies in these pathways are exploited by PARP inhibitors and finally how aberrations of these pathways may be identified and thus used as predictive biomarkers for treatment. The aim of this work is ultimately to allow PARP inhibitor therapy to be targeted to a group of tumours that have a very high chance of responding.
DNA damage repair pathways
The development of a cancer is defined by a pattern of genetic abnormality affecting a cell.
To save this book to your Kindle, first ensure [email protected] is added to your Approved Personal Document E-mail List under your Personal Document Settings on the Manage Your Content and Devices page of your Amazon account. Then enter the ‘name’ part of your Kindle email address below. Find out more about saving to your Kindle.
Note you can select to save to either the @free.kindle.com or @kindle.com variations. ‘@free.kindle.com’ emails are free but can only be saved to your device when it is connected to wi-fi. ‘@kindle.com’ emails can be delivered even when you are not connected to wi-fi, but note that service fees apply.
Find out more about the Kindle Personal Document Service.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Dropbox.
To save content items to your account, please confirm that you agree to abide by our usage policies. If this is the first time you use this feature, you will be asked to authorise Cambridge Core to connect with your account. Find out more about saving content to Google Drive.
